GOSS Gossamer Bio Inc

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ascendis Pharma (ASND – Research Report), Gossamer Bio (GOSS – Research Report) and BioNTech SE (BNTX – Research Report). Ascendis Pharma (ASND) In a report released today, Caroline Palomeque from Berenberg Bank maintained a Buy rating on Ascendis Pharma, with a price target of $166.00. The company's shares closed last Monday at $124.75. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-ascendis-pharma-asnd-gossamer-bio-goss-and-biontech-se-bntx?utm_source=advfn.com&utm_medium=referral